As of 2026-04-08, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (8.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.71 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -160.3%.
The range of the Relative Valuation is (8.44) - (10.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 30.6x | 24.8x |
| Forward P/E multiples | 15.5x - 26.0x | 18.0x |
| Fair Price | (8.44) - (10.05) | (8.27) |
| Upside | -161.6% - -173.3% | -160.3% |
| Date | P/E |
| 2026-04-06 | -36.44 |
| 2026-04-02 | -38.33 |
| 2026-04-01 | -37.34 |
| 2026-03-31 | -35.92 |
| 2026-03-30 | -33.26 |
| 2026-03-27 | -32.12 |
| 2026-03-26 | -36.13 |
| 2026-03-25 | -36.62 |
| 2026-03-24 | -35.97 |
| 2026-03-23 | -35.35 |
| 2026-03-20 | -35.14 |
| 2026-03-19 | -34.94 |
| 2026-03-18 | -34.37 |
| 2026-03-17 | -34.65 |
| 2026-03-16 | -34.47 |
| 2026-03-13 | -34.08 |
| 2026-03-12 | -32.22 |
| 2026-03-11 | -36.80 |
| 2026-03-10 | -37.58 |
| 2026-03-09 | -38.69 |
| 2026-03-06 | -38.46 |
| 2026-03-05 | -41.23 |
| 2026-03-04 | -42.55 |
| 2026-03-03 | -41.61 |
| 2026-03-02 | -41.72 |
| 2026-02-27 | -41.46 |
| 2026-02-26 | -42.60 |
| 2026-02-25 | -41.95 |
| 2026-02-24 | -41.54 |
| 2026-02-23 | -39.83 |
| 2026-02-20 | -39.34 |
| 2026-02-19 | -41.54 |
| 2026-02-18 | -41.07 |
| 2026-02-17 | -40.86 |
| 2026-02-13 | -41.51 |
| 2026-02-12 | -40.22 |
| 2026-02-11 | -40.42 |
| 2026-02-10 | -40.48 |
| 2026-02-09 | -41.04 |
| 2026-02-06 | -40.81 |
| 2026-02-05 | -42.62 |
| 2026-02-04 | -44.77 |
| 2026-02-03 | -47.88 |
| 2026-02-02 | -47.59 |
| 2026-01-30 | -47.88 |
| 2026-01-29 | -47.54 |
| 2026-01-28 | -47.88 |
| 2026-01-27 | -49.77 |
| 2026-01-26 | -49.48 |
| 2026-01-23 | -48.01 |